Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.28−0.01 (-3.78%)
Close on Nov 11, 2026Market cap $1.74MP/E –Yield –
Co-Diagnostics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Co-Diagnostics's ebitda for the twelve months ending Sep 30, 2026 was -$47.27M. For fiscal 2025 it was -$49.06M. The highest annual figure on record is $46.40M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$49.06M | – |
| FY2024 | Dec 31, 2024 | -$38.70M | – |
| FY2023 | Dec 31, 2023 | -$41.48M | – |
| FY2022 | Dec 31, 2022 | -$25.70M | -155.4% |
| FY2021 | Dec 31, 2021 | $46.40M | +10.9% |
| FY2020 | Dec 31, 2020 | $41.83M | – |
| FY2019 | Dec 31, 2019 | -$5.83M | – |
| FY2018 | Dec 31, 2018 | -$6.07M | – |
| FY2017 | Dec 31, 2017 | -$4.52M | – |
| FY2016 | Dec 31, 2016 | -$1.65M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.05M | – |
| Q2 FY2026 | Jun 30, 2026 | -$6.00M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.95M | – |
| Q4 FY2025 | Dec 31, 2025 | -$26.27M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.75M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.77M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.55M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.88M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.51M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.69M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.63M | -195.7% |
| Q4 FY2022 | Dec 31, 2022 | -$25.82M | -348.0% |
| Q3 FY2022 | Sep 30, 2022 | -$6.22M | -145.3% |
| Q2 FY2022 | Jun 30, 2022 | -$3.72M | -131.4% |
| Q1 FY2022 | Mar 31, 2022 | $10.07M | -3.2% |
| Q4 FY2021 | Dec 31, 2021 | $10.41M | -35.3% |
| Q3 FY2021 | Sep 30, 2021 | $13.72M | +13.7% |
| Q2 FY2021 | Jun 30, 2021 | $11.86M | -19.5% |
| Q1 FY2021 | Mar 31, 2021 | $10.40M | – |
| Q4 FY2020 | Dec 31, 2020 | $16.09M | – |
| Q3 FY2020 | Sep 30, 2020 | $12.07M | – |
| Q2 FY2020 | Jun 30, 2020 | $14.73M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.60M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.63M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.35M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.81M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.65M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.27M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.48M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.79M | – |
| Q2 FY2017 | Jun 30, 2017 | -$689.87K | – |
| Q1 FY2017 | Mar 31, 2017 | -$554.64K | – |
| Q4 FY2016 | Dec 31, 2016 | -$436.55K | – |
See a number that looks wrong?